MicroRNAs, Social Defeat Stress, Major Depressive Disorder, and Ketamine Treatment

被引：0
|
作者：
不详
机构：
来源：
NEUROSCIENTIST | 2023年 / 29卷 / 01期
关键词：
D O I：
10.1177/10738584221141676
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [31] Social functioning in major depressive disorder
    Kupferberg, Aleksandra
    Bicks, Lucy
    Hasler, Gregor
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 69 : 313 - 332
  • [32] Modulation of the functional connectome in major depressive disorder by ketamine therapy
    Sahib, Ashish K.
    Loureiro, Joana R.
    Vasavada, Megha
    Anderson, Cole
    Kubicki, Antoni
    Wade, Benjamin
    Joshi, Shantanu H.
    Woods, Roger P.
    Congdon, Eliza
    Espinoza, Randall
    Narr, Katherine L.
    [J]. PSYCHOLOGICAL MEDICINE, 2022, 52 (13) : 2596 - 2605
  • [33] Efficacy of different doses of ketamine as a bolus in major depressive disorder
    Kheirkhah, Farzan
    Tayyebi, Gooya
    Rabiee, Seyed Mozaffar
    Moghadamnia, Ali-Akbar
    Bijani, Ali
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2018, 9 (03) : 220 - 227
  • [34] A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
    Lapidus, Kyle A. B.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Soleimani, Laili
    Feder, Adriana
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 76 (12) : 970 - 976
  • [35] MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
    Ortega, Miguel A.
    Angel Alvarez-Mon, Miguel
    Garcia-Montero, Cielo
    Fraile-Martinez, Oscar
    Lahera, Guillermo
    Monserrat, Jorge
    Munoz-Merida, Luis
    Mora, Fernando
    Rodriguez-Jimenez, Roberto
    Fernandez-Rojo, Sonia
    Quintero, Javier
    Alvarez-Mon, Melchor
    [J]. BIOMEDICINES, 2021, 9 (11)
  • [36] Intravenous Ketamine for Treatment of Major Depressive Disorder in a Patient with a History of Repetitive Traumatic Brain Injuries
    Dougherty, John, III
    [J]. BRAIN INJURY, 2019, 33 : 211 - 212
  • [37] The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
    Boudieu, Ludivine
    Mennetrier, Myriam
    Llorca, Pierre-Michel
    Samalin, Ludovic
    [J]. PHARMACEUTICS, 2023, 15 (12)
  • [38] Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Araujo-de-Freitas, Lucas
    Vieira, Flavia
    Jesus-Nunes, Ana Paula
    Quarantini, Lucas C.
    Sampaio, Aline S.
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2021, 29 (05) : 340 - 350
  • [39] Acupuncture Treatment for Social Defeat Stress
    Kawanokuchi, Jun
    Takagi, Ken
    Tanahashi, Nobuyuki
    Yamamoto, Teruhisa
    Nagaoka, Nobuyuki
    Ishida, Torao
    Ma, Ning
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2021, 15
  • [40] Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder
    Davis, Margaret T.
    DellaGiogia, Nicole
    Maruff, Paul
    Pietrzak, Robert H.
    Esterlis, Irina
    [J]. TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
12345